The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Namasivayam Ambalavanan

Department of Pediatrics

University of Alabama at Birmingham

176F Suite 9380

619 South 20 St.

USA

[email]@uab.edu

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Department of Pediatrics, University of Alabama at Birmingham, 176F Suite 9380, 619 South 20 St., USA. 2003 - 2013
  • 176F Suite 9380, 619 South 20 St., Univ. of Alabama at Birmingham, Birmingham. 2012

References

  1. Titanium oxide nanoparticle instillation induces inflammation and inhibits lung development in mice. Ambalavanan, N., Stanishevsky, A., Bulger, A., Halloran, B., Steele, C., Vohra, Y., Matalon, S. Am. J. Physiol. Lung Cell Mol. Physiol. (2013) [Pubmed]
  2. Outcome trajectories in extremely preterm infants. Ambalavanan, N., Carlo, W.A., Tyson, J.E., Langer, J.C., Walsh, M.C., Parikh, N.A., Das, A., Van Meurs, K.P., Shankaran, S., Stoll, B.J., Higgins, R.D. Pediatrics (2012) [Pubmed]
  3. Transforming growth factor-β regulates endothelin-1 signaling in the newborn mouse lung during hypoxia exposure. Olave, N., Nicola, T., Zhang, W., Bulger, A., James, M., Oparil, S., Chen, Y.F., Ambalavanan, N. Am. J. Physiol. Lung Cell Mol. Physiol. (2012) [Pubmed]
  4. Prospective analysis of pulmonary hypertension in extremely low birth weight infants. Bhat, R., Salas, A.A., Foster, C., Carlo, W.A., Ambalavanan, N. Pediatrics (2012) [Pubmed]
  5. Identification of extremely premature infants at high risk of rehospitalization. Ambalavanan, N., Carlo, W.A., McDonald, S.A., Yao, Q., Das, A., Higgins, R.D. Pediatrics (2011) [Pubmed]
  6. Hypoxia-induced inhibition of lung development is attenuated by the peroxisome proliferator-activated receptor-{gamma} agonist rosiglitazone. Nicola, T., Ambalavanan, N., Zhang, W., James, M.L., Rehan, V., Halloran, B., Olave, N., Bulger, A., Oparil, S., Chen, Y.F. Am. J. Physiol. Lung Cell Mol. Physiol. (2011) [Pubmed]
  7. Intercenter differences in bronchopulmonary dysplasia or death among very low birth weight infants. Ambalavanan, N., Walsh, M., Bobashev, G., Das, A., Levine, B., Carlo, W.A., Higgins, R.D. Pediatrics (2011) [Pubmed]
  8. Cytokines associated with bronchopulmonary dysplasia or death in extremely low birth weight infants. Ambalavanan, N., Carlo, W.A., D'Angio, C.T., McDonald, S.A., Das, A., Schendel, D., Thorsen, P., Higgins, R.D. Pediatrics (2009) [Pubmed]
  9. Nitric oxide administration using an oxygen hood: a pilot trial. Ambalavanan, N., El-Ferzli, G.T., Roane, C., Johnson, R., Carlo, W.A. PLoS. ONE (2009) [Pubmed]
  10. Role of matrix metalloproteinase-2 in newborn mouse lungs under hypoxic conditions. Ambalavanan, N., Nicola, T., Li, P., Bulger, A., Murphy-Ullrich, J., Oparil, S., Chen, Y.F. Pediatr. Res. (2008) [Pubmed]
  11. Transforming growth factor-beta signaling mediates hypoxia-induced pulmonary arterial remodeling and inhibition of alveolar development in newborn mouse lung. Ambalavanan, N., Nicola, T., Hagood, J., Bulger, A., Serra, R., Murphy-Ullrich, J., Oparil, S., Chen, Y.F. Am. J. Physiol. Lung Cell Mol. Physiol. (2008) [Pubmed]
  12. Predictors of death or bronchopulmonary dysplasia in preterm infants with respiratory failure. Ambalavanan, N., Van Meurs, K.P., Perritt, R., Carlo, W.A., Ehrenkranz, R.A., Stevenson, D.K., Lemons, J.A., Poole, W.K., Higgins, R.D. J. Perinatol (2008) [Pubmed]
  13. Endothelin-1 mediates hypoxia-induced increases in vascular collagen in the newborn mouse lung. Ambalavanan, N., Li, P., Bulger, A., Murphy-Ullrich, J., Oparil, S., Chen, Y.F. Pediatr. Res. (2007) [Pubmed]
  14. Endothelin-A receptor blockade inhibits the effects of hypoxia on the newborn lung vasculature. Ambalavanan, N. ScientificWorldJournal (2006) [Pubmed]
  15. Ventilatory strategies in the prevention and management of bronchopulmonary dysplasia. Ambalavanan, N., Carlo, W.A. Semin. Perinatol. (2006) [Pubmed]
  16. Predicting outcomes of neonates diagnosed with hypoxemic-ischemic encephalopathy. Ambalavanan, N., Carlo, W.A., Shankaran, S., Bann, C.M., Emrich, S.L., Higgins, R.D., Tyson, J.E., O'Shea, T.M., Laptook, A.R., Ehrenkranz, R.A., Donovan, E.F., Walsh, M.C., Goldberg, R.N., Das, A. Pediatrics (2006) [Pubmed]
  17. Vitamin A supplementation for extremely low birth weight infants: outcome at 18 to 22 months. Ambalavanan, N., Tyson, J.E., Kennedy, K.A., Hansen, N.I., Vohr, B.R., Wright, L.L., Carlo, W.A. Pediatrics (2005) [Pubmed]
  18. Endothelin-A receptor blockade prevents and partially reverses neonatal hypoxic pulmonary vascular remodeling. Ambalavanan, N., Bulger, A., Murphy-Ullrich, J., Oparil, S., Chen, Y.F. Pediatr. Res. (2005) [Pubmed]
  19. Prediction of death for extremely low birth weight neonates. Ambalavanan, N., Carlo, W.A., Bobashev, G., Mathias, E., Liu, B., Poole, K., Fanaroff, A.A., Stoll, B.J., Ehrenkranz, R., Wright, L.L. Pediatrics (2005) [Pubmed]
  20. Bronchopulmonary dysplasia: new insights. Ambalavanan, N., Carlo, W.A. Clin. Perinatol (2004) [Pubmed]
  21. Survey of vitamin A supplementation for extremely-low-birth-weight infants: is clinical practice consistent with the evidence?. Ambalavanan, N., Kennedy, K., Tyson, J., Carlo, W.A. J. Pediatr. (2004) [Pubmed]
  22. A comparison of three vitamin A dosing regimens in extremely-low-birth-weight infants. Ambalavanan, N., Wu, T.J., Tyson, J.E., Kennedy, K.A., Roane, C., Carlo, W.A. J. Pediatr. (2003) [Pubmed]
 
WikiGenes - Universities